Huperzine A
| HupA | |
|---|---|
| Salts [] | |
|---|---|
| Huperzine A monohydrate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 242.32 g/mol [1] |
| Melting point | 217-219 °C [1] |
| Predicted LogP | 0 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C15H18N2O |
| IUPAC name | (1R,9R,13E)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.02,7]trideca-2(7),3,10-trien-5-one |
| SMILES | C/C=C/1\[C@@H]2CC3=C([C@]1(CC(=C2)C)N)C=CC(=O)N3 |
| InChI | InChI=1S/C15H18N2O/c1-3-11-10-6-9(2)8-15(11,16)12-4-5-14(18)17-13(12)7-10/h3-6,10H,7-8,16H2,1-2H3,(H,17,18)/b11-3+/t10-,15+/m0/s1 |
| InChIKey | ZRJBHWIHUMBLCN-YQEJDHNASA-N |
| CAS number | 102518-79-6 |
| UNII | 0111871I23 |
| PubChem CID | 854026 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 10–14 hours[3] |
| Routes of administration | By mouth |
Huperzine A (also known as (-)-huperzine A, (-)-huperazine A, L-huperzine A, Huperzine-A, Hup A, Kimpukan A, 600-320-6, Selagine, Huperzin A or Huperizine A).
Chemistry
Salts []
Huperzine A is typically found in the form of its monohydrate salt.
Stereochemistry []
Huperzine A is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Huperzine A matches Lipinski's rule of five.Pharmacology
MeSH Classification
Mechanism of action []
Huperzine A has been found to be an inhibitor of the enzyme acetylcholinesterase. This is the same mechanism of action of pharmaceutical drugs such as [galantamine] and [donepezil] used to treat Alzheimer's disease. [1]
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 854026, Huperzine A. Accessed November 22, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/854026
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Huperzine A. UNII: 0111871I23. Global Substance Registration System. Accessed November 22, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/0111871I23
Li YX, Zhang RQ, Li CR, Jiang XH. Pharmacokinetics of huperzine A following oral administration to human volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 2007; 32(4):183–187. PMID 18348466. https://doi.org/10.1007/BF03191002
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 08:01:28 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 08:01:24 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 08:01:24 |
| gsrs | ok | 2026-11-20 08:01:25 |
| hmdb | missing (no HMDB id) | 2026-11-20 08:01:24 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 08:01:29 |
| pubchem | ok | 2026-11-20 08:01:24 |
| missing (no r/tripreports posts mention it) | 2026-11-20 08:01:24 | |
| sider | missing (not in SIDER) | 2026-11-20 08:01:24 |
| structure | ok | 2026-11-20 08:01:24 |
| wikipedia | ok | 2026-11-20 08:01:24 |